The Journal of Phytopharmacology 2023; 12(4):258-264 ; DOI:10.31254/phyto.2023.12408
Kabhasura Kudineer and its ingredients against COVID -19
Geetha A1 , Bharatha Jothi P2 , Sushil Kumar PN3 , Kiruthiga G4
1. Ph D Scholar, Tanjore Tamil University, Tanjavur, Tamil Nadu, India
2. Professor and Head of the Department, Tanjore Tamil University, Tanjavur, Tamil Nadu, India
3. Assistant Medical Officer (Siddha), R K Pet, PHC, Thriruvallur, Tamil Nadu, India
4. Research Officer (Siddha), CCRS, Chennai, Tamil Nadu, India
*Author to whom correspondence should be addressed.
Received: 6th July, 2023 / Accepted: 21st August, 2023 / Published : 31st August, 2023
Siddha System of Medicine is one of the folklore medicines practised by people in South India since several years about 12000 yrs back. Ancient people were aware of knowledge in herbs and its uses. They were also handled several such pandemic conditions on that period itself by Notification, Isolation and used some concoction one such medicine is Kabhasura Kudineer (KSK). It is the Siddha formulation contain 15 ingredients mainly prescribed by Siddha Physicians against Viral Diseases like COVID-19 etc., Covid 19 disease is caused by the virus SARS-COVID virus which is come under CORONA Virus. It causes severe acute respiratory syndrome. This virus is highly contagious through nasal and oral secretions caused a pandemic of acute respiratory disease, which threatens human health and public safety. Several crores were affected and several deaths were recorded for the past 2 years. KSK prescribed for COVID-19 diseases in South India because of the ingredients contain Anti –inflammatory, Anti pyretic and Anti – viral activity. This article ensures the chemical constituents of the KSK ingredients and its actions. Furthermore, preclinical study required for confirmation of the action of the KSK.
Siddha, Kabhasura Kudineer, SARS-COVID, Antiviral, Antiinflammatory, Antipyretic
HOW TO CITE THIS ARTICLE
Geetha A, Bharatha Jothi P, Sushil Kumar PN, Kiruthiga G. Kabhasura Kudineer and its ingredients against COVID -19. J Phytopharmacol 2023; 12(4):258-264. doi: 10.31254/phyto.2023.12408
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.